Connection
Nikki Farnsworth to Hypoglycemic Agents
This is a "connection" page, showing publications Nikki Farnsworth has written about Hypoglycemic Agents.
|
|
Connection Strength |
|
 |
|
 |
|
0.841 |
|
|
|
-
Collins J, Farnsworth NL. Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers. Diabetologia. 2025 Apr; 68(4):692-703.
Score: 0.509
-
Farnsworth NL, Walter R, Piscopio RA, Schleicher WE, Benninger RKP. Exendin-4 overcomes cytokine-induced decreases in gap junction coupling via protein kinase A and Epac2 in mouse and human islets. J Physiol. 2019 01; 597(2):431-447.
Score: 0.332